Venetoclax plus azacitidine and LDAC induced high response rates in acute myeloid leukaemia in routine clinical practice. Liu Y, Zhu L, Lv Z, Mao L, et al. Br J Haematol 2023;201:995-999.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu Y, Zhu L, Lv Z, Mao L, et al. Venetoclax plus azacitidine and LDAC induced high response rates in acute myeloid leukaemia in routine clinical practice. Br J Haematol 2023;201:995-999.
PMID: 36999439